Dosimetric Analysis of Brachial Plexopathy after Stereotactic Body Radiotherapy: Significance of Organ Delineation

Stereotactic body radiation therapy (SBRT) is a standard treatment for inoperable early-stage non-small cell lung cancer (NSCLC) and various oligometastatic tumors [1 –4], achieving excellent local tumor control and overall survival through highly conformal dose distribution and ablative regimens [5,6]. However, for lesions in the apical lung and neck regions, the determination of an ablative regimen while controlling toxicity of the brachial plexus (BP) still perplexes clinicians [7,8].

Source: Radiotherapy and Oncology - November 21, 2023 Category: Radiology Authors: Geng-Min Niu, Miao-Miao Gao, Xiao-Feng Wang, Yang Dong, Yi-Fan Zhang, Huan-Huan Wang, Yong Guan, Ze-Yuan Cheng, Shu-Zhou Zhao, Yong-Chun Song, Zhen Tao, Lu-Jun Zhao, Mao-Bin Meng, Feng-Ming Spring Kong, Zhi-Yong Yuan Tags: Original Article Source Type: research